Records 1 - 8
| Current Evidence of the Efficacy and Safety of Neoadjuvant EGFR-TKIs for Patients With Non-small Cell Lung Cancer.
Frontiers in oncology 2021 11 608608.
Shi Xiaoshun, Dong Xiaoying, Zhai Jianxue, Liu Xiguang, Lu Di, Ni Zhen, Wu Hua, Cai Kaic
| Efficacy and safety of erlotinib combined with bevacizumab in the treatment of non-small cell lung cancer: A systematic review and meta-analysis.
Medicine 2020 Jan 99 (3): e18771.
Zhou Kenan, Zhao Shishun, Guo Wenlai, Ding L
| Pemetrexed/carboplatin plus gefitinib as a first-line treatment for EGFR-mutant advanced nonsmall cell lung cancer: a Bayesian network meta-analysis.
Therapeutic advances in medical oncology 2019 11 1758835919891652.
Zhang Zhonghan, Zeng Kangmei, Zhao Shen, Zhao Yuanyuan, Hou Xue, Luo Fan, Lu Feiteng, Zhang Yaxiong, Zhou Ting, Ma Yuxiang, Yang Yunpeng, Fang Wenfeng, Huang Yan, Zhang Li, Zhao Hongy
| Comparison of gefitinib, erlotinib and afatinib in non-small cell lung cancer: A meta-analysis.
International journal of cancer 2017 06 140 (12): 2805-2819.
Yang Zuyao, Hackshaw Allan, Feng Qi, Fu Xiaohong, Zhang Yuelun, Mao Chen, Tang Jinli
| Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR-Mutated Non-Small Cell Lung Cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Dec .
Ding Pei Ni, Lord Sarah J, Gebski Val, Links Matthew, Bray Victoria, Gralla Richard J, Yang James Chih-Hsin, Lee Chee Kho
| Efficacy of epidermal growth factor receptor inhibitors in combination with chemotherapy in advanced non-small cell lung cancer: a meta-analysis of randomized controlled trials.
Oncotarget 2016 May .
Zhang Minghui, Guo Hongsheng, Zhao Shu, Wang Yan, Yang Maopeng, Yu Jiawei, Yan Yubo, Wang Y
| Network meta-analysis of erlotinib, gefitinib, afatinib and icotinib in patients with advanced non-small-cell lung cancer harboring EGFR mutations.
PloS one 2014 9 (2): e85245.
Liang Wenhua, Wu Xuan, Fang Wenfeng, Zhao Yuanyuan, Yang Yunpeng, Hu Zhihuang, Xue Cong, Zhang Jing, Zhang Jianwei, Ma Yuxiang, Zhou Ting, Yan Yue, Hou Xue, Qin Tao, Dinglin Xiaoxiao, Tian Ying, Huang Peiyu, Huang Yan, Zhao Hongyun, Zhang
| Combination of EGFR-TKIs and chemotherapy as first-line therapy for advanced NSCLC: a meta-analysis.
PloS one 2013 8 (11): e79000.
OuYang Pu-Yun, Su Zhen, Mao Yan-Ping, Deng Wuguo, Xie Fang-Y